October 3, 2022

FDA Rejects Another Weight Loss Pill

Last week the FDA rejected the weight loss pill lorcaserin. This week they have rejected Vivus Inc.’s drug, Qnexa. This represents quite a setback for those trying to get a handle on obesity in America. This is also the third weight loss pill to be rejected this month. In July, a panel of experts had […]